Impact of rosiglitazone safety alerts on oral antidiabetic sales trends: a countrywide study in Portugal.

about

Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerations.Trends in the incidence of use of noninsulin glucose-lowering drugs between 2006 and 2013 in France.

P2860

Q47653552-FB29A887-B065-49A9-A41C-081E2DC89673 Q48334652-5BD1E63E-140A-49C1-B470-345DC6782B71

P2860

Impact of rosiglitazone safety alerts on oral antidiabetic sales trends: a countrywide study in Portugal.

Item

http://www.wikidata.org/entity/Q39711572

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Impact of rosiglitazone safety ...... countrywide study in Portugal.

@en

Impact of rosiglitazone safety ...... countrywide study in Portugal.

@nl

type

Item

label

Impact of rosiglitazone safety ...... countrywide study in Portugal.

@en

Impact of rosiglitazone safety ...... countrywide study in Portugal.

@nl

prefLabel

Impact of rosiglitazone safety ...... countrywide study in Portugal.

@en

Impact of rosiglitazone safety ...... countrywide study in Portugal.

@nl

P1476

Impact of rosiglitazone safety ...... countrywide study in Portugal

@en

P2093

Tânia Silva

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

Changes in glitazone use among office-based physicians in the U.S., 2003-2009.

Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality.

Adverse drug event monitoring at the Food and Drug Administration.

Impact of mailed warning to prescribers on the co-prescription of tramadol and antidepressants.

Impact of regulatory labeling for troglitazone and rosiglitazone on hepatic enzyme monitoring compliance: findings from the state of Ohio medicaid program.

Prescribing pattern of glucose lowering drugs in the United Kingdom in the last decade: a focus on the effects of safety warnings about rosiglitazone.

Temporal trends in anti-diabetes drug use in TRICARE following safety warnings in 2007 about rosiglitazone.

Impact of a health safety warning and prior authorisation on the use of piroxicam: a time-series study.

Impact of safety-related regulatory action on clinical practice: a systematic review.

P304

440-449

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/FCP.12207

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27259384

http://www.w3.org/2001/XMLSchema#string

P921

Portugal

Impact of rosiglitazone safety alerts on oral antidiabetic sales trends: a countrywide study in Portugal.

about

P2860

P2860

Impact of rosiglitazone safety alerts on oral antidiabetic sales trends: a countrywide study in Portugal.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921